MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 273-278

  Zhang, Huanle ^a   Li, Weihua ^b   Nan, Feifei ^a   Ren, Fang ^a   Wang, Hongxia ^a   Xu, Yingchun ^a   Zhang, Fengchun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

Cancer stem cells; CD133; Colon cancer; MicroRNA

Indexed keywords

BMI1 PROTEIN; CD133 ANTIGEN; MICRORNA; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; WNT2 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL REGENERATION; COLON ADENOCARCINOMA; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HT29 CELLS; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS;

EID: 78650858779     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.106     Document Type: Article

References (34)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59:225-249.
2. Huang E.H., Wicha M.S. Colon cancer stem cells: implications for prevention and therapy. Trends Mol. Med. 2008, 14:503-509.
3. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3:895-902.
4. Tan B.T., Park C.Y., Ailles L.E., Weissman I.L. The cancer stem cell hypothesis: a work in progress. Lab. Invest. 2006, 86:1203-1207.
5. Chen Y.C., Hsu H.S., Chen Y.W., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008, 3:e2637.
6. Gangemi R.M., Griffero F., Marubbi D., et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27:40-48.
7. Todaro M., Alea M.P., Di Stefano A.B., et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402.
8. Nicoloso M.S., Spizzo R., Shimizu M., et al. MicroRNAs - the micro steering wheel of tumour metastases. Nat. Rev. Cancer 2009, 9:293-302.
9. Gal H., Pandi G., Kanner A.A., et al. miR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem. Biophys. Res. Commun. 2008, 376:86-90.
10. Lee N.S., Kim J.S., Cho W.J., et al. miR-302b maintains " stemness" of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Biochem. Biophys. Res. Commun. 2008, 377:434-440.
11. Qian S., Ding J.Y., Xie R., et al. MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem. Biophys. Res. Commun. 2008, 377:668-673.
12. Yu F., Yao H., Zhu P., et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123.
13. Shimono Y., Zabala M., Cho R.W., et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
14. Ieta K., Tanaka F., Haraguchi N., et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann. Surg. Oncol. 2008, 15:638-648.
15. O'Brien C.A., Pollett A., Gallinger S., et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
16. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon cancer initiating cells. Nature 2007, 445:111-115.
17. Vermeulen L., Todaro M., De Sousa Mello F., et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 2008, 105:13427-13432.
18. Park S.M., Gaur A.B., Lengyel E., et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
19. Kong W., Yang H., He L., et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 2008, 28:6773-6784.
20. Liu L., Jiang Y., Zhang H., et al. Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Life Sci. 2010, 86:192-198.
21. Schepeler T., Reinert J.T., Ostenfeld M.S., et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008, 68:6416-6424.
22. Zhang B., Wang X., Wang Y. Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. J. Exp. Clin. Cancer Res. 2009, 28:56.
23. Spahn M., Kneitz S., Scholz C.J., et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int. J. Cancer 2009, 127:394-403.
24. Valastyan S., Reinhardt F., Benaich N., et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
25. Ma S., Chan K.W., Hu L., et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
26. Bertolini G., Roz L., Perego P., et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 2009, 106:16281-16286.
27. Saigusa S., Tanaka K., Toiyama Y., et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 2009, 16:3488-3498.
28. Vermeulen L., DeSousa E.M.F., van der Heijden M., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
29. Hatfield S.D., Shcherbata H.R., Fischer K.A., et al. Stem cell division is regulated by the microRNA pathway. Nature 2005, 435:974-978.
30. Ivey K.N., Muth A., Arnold J., et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008, 2:219-229.
31. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852.
32. Morel A.P., Lievre M., Thomas C., et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888.
33. Jiang S., Zhang H.W., Lu M.H., et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010, 70:3119-3127.
34. Benakanakere M.R., Li Q., Eskan M.A., Singh A.V., et al. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J. Biol. Chem. 2009, 284:23107-23115.